Record Information |
---|
Version | 5.0 |
---|
Status | Detected and Quantified |
---|
Creation Date | 2006-08-16 15:10:22 UTC |
---|
Update Date | 2022-03-07 02:49:10 UTC |
---|
HMDB ID | HMDB0001449 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Allopregnanolone |
---|
Description | Allopregnanolone is a neuroactive metabolite of progesterone and a barbiturate-like modulator of central gamma-aminobutyric acid receptors that modify a range of behaviors, including the stress response. is a steroid created in the body when progesterone, the female sex hormone, is metabolized. Typically, THP (allopregnanolone) is released in the brain in response to stress, and quiets the neural system within 30 minutes of escalation. This steroid hormone has recently been found to be responsible for the extreme mood swings found in teenagers. In adults and pre-pubescent chlidren THP normally helps soothe the activity of brain cells by binding to GABA receptors that inhibit accelerating electrical activity. However, in pubescent teenagers THP actually becomes a GABA receptor antagonist. GABA (gamma-aminobutyric acid) is the primary inhibitory neurotransmitter in the brain with most sedatives (tranquilizers, anesthetics and alcohol) acting on the GABA receptor. |
---|
Structure | [H][C@@]1(CC[C@@]2([H])[C@]3([H])CC[C@@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)C(C)=O InChI=1S/C21H34O2/c1-13(22)17-6-7-18-16-5-4-14-12-15(23)8-10-20(14,2)19(16)9-11-21(17,18)3/h14-19,23H,4-12H2,1-3H3/t14-,15+,16-,17+,18-,19-,20-,21+/m0/s1 |
---|
Synonyms | Value | Source |
---|
(3alpha,5alpha)-3-Hydroxypregnan-20-one | ChEBI | 3alpha,5alpha-Tetrahydroprogesterone | ChEBI | 3alpha,5alpha-THP | ChEBI | 3alpha-Hydroxy-5alpha-dihydroprogesterone | ChEBI | 3alpha-Hydroxy-5alpha-pregnan-20-one | ChEBI | 3alpha-OH DHP | ChEBI | 5alpha-Pregnan-3alpha-ol-20-one | ChEBI | Allopregnan-3alpha-ol-20-one | ChEBI | Allotetrahydroprogesterone | ChEBI | Brexanolona | ChEBI | Brexanolonum | ChEBI | SAGE-547 | ChEBI | SGE-102 | ChEBI | Zulresso | ChEBI | (3a,5a)-3-Hydroxypregnan-20-one | Generator | (3Α,5α)-3-hydroxypregnan-20-one | Generator | 3a,5a-Tetrahydroprogesterone | Generator | 3Α,5α-tetrahydroprogesterone | Generator | 3a,5a-THP | Generator | 3Α,5α-THP | Generator | 3a-Hydroxy-5a-dihydroprogesterone | Generator | 3Α-hydroxy-5α-dihydroprogesterone | Generator | 3a-Hydroxy-5a-pregnan-20-one | Generator | 3Α-hydroxy-5α-pregnan-20-one | Generator | 3a-OH DHP | Generator | 3Α-OH DHP | Generator | 5a-Pregnan-3a-ol-20-one | Generator | 5Α-pregnan-3α-ol-20-one | Generator | Allopregnan-3a-ol-20-one | Generator | Allopregnan-3α-ol-20-one | Generator | (+)-3a-Hydroxy-5a-pregnan-20-one | HMDB | (3a)-Allopregnanolone | HMDB | 3-a-Tetrahydroprogesterone | HMDB | 3-alpha-Tetrahydroprogesterone | HMDB | 3a,5a-Pregnanolone | HMDB | 3a-Hydroxy-5a-pregnane-20-one | HMDB | 5a-Pregnane-3a-ol-20-one | HMDB | 3-Hydroxypregnan-20-one | HMDB | alpha-Hydroxy-5 alpha-pregnan-20-one, 3 | HMDB | Pregnan-3alpha-ol-20-one | HMDB | Pregnanolone, (3alpha)-isomer | HMDB | 3 Hydroxypregnan 20 one | HMDB | 3 alpha Hydroxy 5 alpha pregnan 20 one | HMDB | 3 alpha-Hydroxy-5 alpha-pregnan-20-one | HMDB | Pregnan 3alpha ol 20 one | HMDB | alpha-Pregnan-20-one, 3 alpha-hydroxy-5 | HMDB | (+)-3alpha-Hydroxy-5alpha-pregnan-20-one | HMDB | (+)-3Α-hydroxy-5α-pregnan-20-one | HMDB | (3alpha)-Allopregnanolone | HMDB | (3Α)-allopregnanolone | HMDB | 3alpha,5alpha-Pregnanolone | HMDB | 3alpha-Hydroxy-5alpha-pregnane-20-one | HMDB | 3Α,5α-pregnanolone | HMDB | 3Α-hydroxy-5α-pregnane-20-one | HMDB | 5alpha-Pregnane-3alpha-ol-20-one | HMDB | 5Α-pregnane-3α-ol-20-one | HMDB | Allopregnanolone | MeSH, ChEBI |
| Show more...
---|
Chemical Formula | C21H34O2 |
---|
Average Molecular Weight | 318.4935 |
---|
Monoisotopic Molecular Weight | 318.255880332 |
---|
IUPAC Name | 1-[(1S,2S,5R,7S,10R,11S,14S,15S)-5-hydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-14-yl]ethan-1-one |
---|
Traditional Name | 1-[(1S,2S,5R,7S,10R,11S,14S,15S)-5-hydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-14-yl]ethanone |
---|
CAS Registry Number | 516-54-1 |
---|
SMILES | [H][C@@]1(CC[C@@]2([H])[C@]3([H])CC[C@@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)C(C)=O |
---|
InChI Identifier | InChI=1S/C21H34O2/c1-13(22)17-6-7-18-16-5-4-14-12-15(23)8-10-20(14,2)19(16)9-11-21(17,18)3/h14-19,23H,4-12H2,1-3H3/t14-,15+,16-,17+,18-,19-,20-,21+/m0/s1 |
---|
InChI Key | AURFZBICLPNKBZ-SYBPFIFISA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as gluco/mineralocorticoids, progestogins and derivatives. These are steroids with a structure based on a hydroxylated prostane moiety. |
---|
Kingdom | Organic compounds |
---|
Super Class | Lipids and lipid-like molecules |
---|
Class | Steroids and steroid derivatives |
---|
Sub Class | Pregnane steroids |
---|
Direct Parent | Gluco/mineralocorticoids, progestogins and derivatives |
---|
Alternative Parents | |
---|
Substituents | - Progestogin-skeleton
- 20-oxosteroid
- 3-hydroxysteroid
- Hydroxysteroid
- 3-alpha-hydroxysteroid
- Oxosteroid
- Cyclic alcohol
- Ketone
- Secondary alcohol
- Organooxygen compound
- Hydrocarbon derivative
- Organic oxide
- Organic oxygen compound
- Carbonyl group
- Alcohol
- Aliphatic homopolycyclic compound
|
---|
Molecular Framework | Aliphatic homopolycyclic compounds |
---|
External Descriptors | - 3-hydroxy-5alpha-pregnan-20-one (CHEBI:50169 )
- C21 steroids (gluco/mineralocorticoids, progestogins) and derivatives (LMST02030156 )
|
---|
Ontology |
---|
Physiological effect | |
---|
Disposition | |
---|
Process | |
---|
Role | |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | 177 °C | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | | Show more...
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Allopregnanolone,1TMS,isomer #1 | CC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@H](O[Si](C)(C)C)CC[C@]4(C)[C@H]3CC[C@]12C | 2738.7 | Semi standard non polar | 33892256 | Allopregnanolone,1TMS,isomer #2 | CC(O[Si](C)(C)C)=C1CC[C@H]2[C@@H]3CC[C@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C | 2783.9 | Semi standard non polar | 33892256 | Allopregnanolone,1TMS,isomer #3 | C=C(O[Si](C)(C)C)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C | 2734.6 | Semi standard non polar | 33892256 | Allopregnanolone,2TMS,isomer #1 | CC(O[Si](C)(C)C)=C1CC[C@H]2[C@@H]3CC[C@H]4C[C@H](O[Si](C)(C)C)CC[C@]4(C)[C@H]3CC[C@]12C | 2787.6 | Semi standard non polar | 33892256 | Allopregnanolone,2TMS,isomer #1 | CC(O[Si](C)(C)C)=C1CC[C@H]2[C@@H]3CC[C@H]4C[C@H](O[Si](C)(C)C)CC[C@]4(C)[C@H]3CC[C@]12C | 2777.0 | Standard non polar | 33892256 | Allopregnanolone,2TMS,isomer #1 | CC(O[Si](C)(C)C)=C1CC[C@H]2[C@@H]3CC[C@H]4C[C@H](O[Si](C)(C)C)CC[C@]4(C)[C@H]3CC[C@]12C | 3133.8 | Standard polar | 33892256 | Allopregnanolone,2TMS,isomer #2 | C=C(O[Si](C)(C)C)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@H](O[Si](C)(C)C)CC[C@]4(C)[C@H]3CC[C@]12C | 2760.9 | Semi standard non polar | 33892256 | Allopregnanolone,2TMS,isomer #2 | C=C(O[Si](C)(C)C)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@H](O[Si](C)(C)C)CC[C@]4(C)[C@H]3CC[C@]12C | 2765.2 | Standard non polar | 33892256 | Allopregnanolone,2TMS,isomer #2 | C=C(O[Si](C)(C)C)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@H](O[Si](C)(C)C)CC[C@]4(C)[C@H]3CC[C@]12C | 3230.8 | Standard polar | 33892256 | Allopregnanolone,1TBDMS,isomer #1 | CC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@H](O[Si](C)(C)C(C)(C)C)CC[C@]4(C)[C@H]3CC[C@]12C | 2985.7 | Semi standard non polar | 33892256 | Allopregnanolone,1TBDMS,isomer #2 | CC(O[Si](C)(C)C(C)(C)C)=C1CC[C@H]2[C@@H]3CC[C@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C | 3032.5 | Semi standard non polar | 33892256 | Allopregnanolone,1TBDMS,isomer #3 | C=C(O[Si](C)(C)C(C)(C)C)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C | 2995.8 | Semi standard non polar | 33892256 | Allopregnanolone,2TBDMS,isomer #1 | CC(O[Si](C)(C)C(C)(C)C)=C1CC[C@H]2[C@@H]3CC[C@H]4C[C@H](O[Si](C)(C)C(C)(C)C)CC[C@]4(C)[C@H]3CC[C@]12C | 3282.4 | Semi standard non polar | 33892256 | Allopregnanolone,2TBDMS,isomer #1 | CC(O[Si](C)(C)C(C)(C)C)=C1CC[C@H]2[C@@H]3CC[C@H]4C[C@H](O[Si](C)(C)C(C)(C)C)CC[C@]4(C)[C@H]3CC[C@]12C | 3254.0 | Standard non polar | 33892256 | Allopregnanolone,2TBDMS,isomer #1 | CC(O[Si](C)(C)C(C)(C)C)=C1CC[C@H]2[C@@H]3CC[C@H]4C[C@H](O[Si](C)(C)C(C)(C)C)CC[C@]4(C)[C@H]3CC[C@]12C | 3369.8 | Standard polar | 33892256 | Allopregnanolone,2TBDMS,isomer #2 | C=C(O[Si](C)(C)C(C)(C)C)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@H](O[Si](C)(C)C(C)(C)C)CC[C@]4(C)[C@H]3CC[C@]12C | 3288.7 | Semi standard non polar | 33892256 | Allopregnanolone,2TBDMS,isomer #2 | C=C(O[Si](C)(C)C(C)(C)C)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@H](O[Si](C)(C)C(C)(C)C)CC[C@]4(C)[C@H]3CC[C@]12C | 3256.2 | Standard non polar | 33892256 | Allopregnanolone,2TBDMS,isomer #2 | C=C(O[Si](C)(C)C(C)(C)C)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@H](O[Si](C)(C)C(C)(C)C)CC[C@]4(C)[C@H]3CC[C@]12C | 3436.2 | Standard polar | 33892256 |
| Show more...
---|
Spectra |
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental GC-MS | GC-MS Spectrum - Allopregnanolone GC-MS (1 MEOX; 1 TMS) | splash10-0udi-6910000000-837b37f206729753b640 | 2014-06-16 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - Allopregnanolone GC-MS (Non-derivatized) | splash10-0udi-6910000000-837b37f206729753b640 | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Allopregnanolone GC-MS (Non-derivatized) - 70eV, Positive | splash10-1174-0292000000-fb2c0f3a1cfddb10cb08 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Allopregnanolone GC-MS (1 TMS) - 70eV, Positive | splash10-004i-2139000000-ab8a6de8f5a129af086e | 2017-10-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Allopregnanolone GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Allopregnanolone 10V, Positive-QTOF | splash10-0uxr-0129000000-90e5fcb36022dd1ba688 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Allopregnanolone 20V, Positive-QTOF | splash10-0uxr-0396000000-4c39fe7ccd8e0c86e179 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Allopregnanolone 40V, Positive-QTOF | splash10-0006-2490000000-7ac55935cc0d4da95860 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Allopregnanolone 10V, Negative-QTOF | splash10-014i-0029000000-fa09e69c9c0b6736d2e7 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Allopregnanolone 20V, Negative-QTOF | splash10-014i-0069000000-d1d57e3e1a99da4ed11f | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Allopregnanolone 40V, Negative-QTOF | splash10-0zg0-1193000000-44d1597a59ac11f16a41 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Allopregnanolone 10V, Positive-QTOF | splash10-0gb9-0019000000-5b53b3ba37ccafca449f | 2021-09-23 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Allopregnanolone 20V, Positive-QTOF | splash10-0lgi-1797000000-c11629ffa10cac4be118 | 2021-09-23 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Allopregnanolone 40V, Positive-QTOF | splash10-0a4m-8910000000-2813a600e98ff5997275 | 2021-09-23 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Allopregnanolone 10V, Negative-QTOF | splash10-014i-0009000000-bbaa566ea695ae62f84e | 2021-09-25 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Allopregnanolone 20V, Negative-QTOF | splash10-014i-0029000000-ac1c6a15538469151b6c | 2021-09-25 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Allopregnanolone 40V, Negative-QTOF | splash10-00ks-0093000000-db70f670eb2440b743f9 | 2021-09-25 | Wishart Lab | View Spectrum |
| Show more...
---|
Biological Properties |
---|
Cellular Locations | |
---|
Biospecimen Locations | - Blood
- Cerebrospinal Fluid (CSF)
|
---|
Tissue Locations | Not Available |
---|
Pathways | |
---|
Normal Concentrations |
---|
| |
Blood | Detected and Quantified | 0.01 +/- 0.003 uM | Adult (>18 years old) | Female | Normal | | details | Blood | Detected and Quantified | 0.001 +/- 0.00025 uM | Adult (>18 years old) | Both | Normal | | details | Blood | Detected and Quantified | 0.0002 +/- 0.000062 uM | Adult (>18 years old) | Male | Normal | | details | Cerebrospinal Fluid (CSF) | Detected and Quantified | 0.00016 +/- 0.00011 uM | Adult (>18 years old) | Male | Normal | | details |
|
---|
Abnormal Concentrations |
---|
| |
Blood | Detected and Quantified | 0.011 +/- 0.002 uM | Adult (>18 years old) | Female | Prepartum depression | | details | Blood | Detected and Quantified | 0.001 +/- 0.00028 uM | Adult (>18 years old) | Both | Psychiatric disorder | | details | Cerebrospinal Fluid (CSF) | Detected and Quantified | 0.0000150 +/- 0.0000015 uM | Adult (>18 years old) | Both | Major depression | | details |
|
---|
Associated Disorders and Diseases |
---|
Disease References | Alcoholism |
---|
- Nieminen LR, Makino KK, Mehta N, Virkkunen M, Kim HY, Hibbeln JR: Relationship between omega-3 fatty acids and plasma neuroactive steroids in alcoholism, depression and controls. Prostaglandins Leukot Essent Fatty Acids. 2006 Oct-Nov;75(4-5):309-14. Epub 2006 Sep 7. [PubMed:16959481 ]
| Prepartum depression |
---|
- Pearson Murphy BE, Steinberg SI, Hu FY, Allison CM: Neuroactive ring A-reduced metabolites of progesterone in human plasma during pregnancy: elevated levels of 5 alpha-dihydroprogesterone in depressed patients during the latter half of pregnancy. J Clin Endocrinol Metab. 2001 Dec;86(12):5981-7. [PubMed:11739473 ]
| Major depressive disorder |
---|
- Uzunova V, Sheline Y, Davis JM, Rasmusson A, Uzunov DP, Costa E, Guidotti A: Increase in the cerebrospinal fluid content of neurosteroids in patients with unipolar major depression who are receiving fluoxetine or fluvoxamine. Proc Natl Acad Sci U S A. 1998 Mar 17;95(6):3239-44. [PubMed:9501247 ]
- Nieminen LR, Makino KK, Mehta N, Virkkunen M, Kim HY, Hibbeln JR: Relationship between omega-3 fatty acids and plasma neuroactive steroids in alcoholism, depression and controls. Prostaglandins Leukot Essent Fatty Acids. 2006 Oct-Nov;75(4-5):309-14. Epub 2006 Sep 7. [PubMed:16959481 ]
|
|
---|
Associated OMIM IDs | - 608516 (Major depressive disorder)
|
---|
External Links |
---|
DrugBank ID | DB11859 |
---|
Phenol Explorer Compound ID | Not Available |
---|
FooDB ID | FDB022630 |
---|
KNApSAcK ID | Not Available |
---|
Chemspider ID | 83760 |
---|
KEGG Compound ID | C13712 |
---|
BioCyc ID | Not Available |
---|
BiGG ID | Not Available |
---|
Wikipedia Link | Allopregnanolone |
---|
METLIN ID | Not Available |
---|
PubChem Compound | 92786 |
---|
PDB ID | Not Available |
---|
ChEBI ID | 50169 |
---|
Food Biomarker Ontology | Not Available |
---|
VMH ID | CE2211 |
---|
MarkerDB ID | MDB00000326 |
---|
Good Scents ID | Not Available |
---|
References |
---|
Synthesis Reference | Wiebe, J. P.; Deline, C.; Buckingham, K. D.; Dave, Vinod; Stothers, J. B. Synthesis of the allylic gonadal steroids, 3a-hydroxy-4-pregnen-20-one and 3a-hydroxy-4-androsten-17-one, and of 3a-hydroxy-5a-pregnan-20-one. Steroids (1985), 45(1), 39-51. |
---|
Material Safety Data Sheet (MSDS) | Not Available |
---|
General References | - Kim YS, Zhang H, Kim HY: Profiling neurosteroids in cerebrospinal fluids and plasma by gas chromatography/electron capture negative chemical ionization mass spectrometry. Anal Biochem. 2000 Jan 15;277(2):187-95. [PubMed:10625505 ]
- Pearson Murphy BE, Steinberg SI, Hu FY, Allison CM: Neuroactive ring A-reduced metabolites of progesterone in human plasma during pregnancy: elevated levels of 5 alpha-dihydroprogesterone in depressed patients during the latter half of pregnancy. J Clin Endocrinol Metab. 2001 Dec;86(12):5981-7. [PubMed:11739473 ]
- Uzunova V, Sheline Y, Davis JM, Rasmusson A, Uzunov DP, Costa E, Guidotti A: Increase in the cerebrospinal fluid content of neurosteroids in patients with unipolar major depression who are receiving fluoxetine or fluvoxamine. Proc Natl Acad Sci U S A. 1998 Mar 17;95(6):3239-44. [PubMed:9501247 ]
|
---|